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Abstract Propionibacterium acnes ( P. acnes) has been
known to produce various exogenous proteases, however,
their role in acne pathogenesis remains largely unknown.
Proteases elicit cellular responses, at least in part, via pro-
teinase-activated receptor-2 (PAR-2), which is known to
mediate inXammation and immune response. In this study,
we investigated whether proteases from P. acnes could acti-
vate PAR-2 on keratinocytes and induce pro-inXammatory
cytokines, antimicrobial peptides (AMPs), and matrix
metalloproteinases (MMPs) via PAR-2 signaling. We
examined PAR-2 expression and protease activity in acne
lesions using immunoXuorescence staining and in situ
zymography. The eVect of the culture supernatant of
P. acnes on Ca2+ signaling in immortalized keratinocytes
(HaCaT) was measured using a Xuorescence method.
HaCaT cells were treated with P. acnes strain ATCC 6919
culture supernatant, with or without pretreatment with
serine protease inhibitor or selective PAR-2 antagonist and
the gene expression of pro-inXammatory cytokines, AMPs,
and MMPs was detected using real-time reverse transcrip-
tion-polymerase chain reaction. We found that the protease
activity and PAR-2 expression were increased in acne
lesions. The P. acnes culture supernatant induced calcium
signaling in keratinocytes via PAR-2 and stimulated the
mRNA expression of interleukin (IL)-1, -8, tumor necro-
sis factor (TNF)-, human beta defensin (hBD)-2, LL-37,
MMP-1, -2, -3, -9, and -13 in keratinocytes, which was sig-
niWcantly inhibited by serine protease inhibitor as well as
selective PAR-2 speciWc antagonist. These results indicate
that PAR-2 plays an important role in the pathogenesis of
acne by inducing inXammatory mediators in response to
proteases secreted from P. acnes.
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Introduction
Acne vulgaris is a chronic inXammatory disorder of pilose-
baceous unit characterized by increased sebum production,
altered keratinization, Propionibacterium acnes (P. acnes)
colonization, and inXammation [35].  Propionibacterium
acnes, which is a facultative anaerobic gram-positive bacte-
rium, is believed to play a critical role in the induction and
maintenance of inXammation in acne by activating inXam-
matory cells, keratinocytes, and sebocytes to induce various
inXammatory mediators [3,  23]. It is now accepted that
P. acnes contributes to inXammation via activation of toll-like
receptors (TLRs) [17, 18]. It is also known that, besides
TLRs activation, P. acnes triggers acne inXammation by
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releasing various enzymes which lead to rupture of follicu-
lar walls and tissue injury such as lipases, proteases and
hyaluronidases [8, 10, 28]. A previous study showed that
P. acnes, laboratory strain P-37, produced extracellular pro-
teinase, which was a heterogeneous mixture of three molec-
ular species of enzyme including a neutral proteinase with a
serine group and two kinds of alkaline proteinases [10]. In
addition, the genome sequence of P. acnes demonstrated
various extracellular peptidases, including homologs of an
O-sialoglycoprotein endopeptidase, an extracellular subtili-
sin-like protease and a tripeptidyl aminopeptidase [4].
Extracellular proteases secreted by P. acnes may contribute
to inXammation of acne by matrix breakdown and proteo-
lytic detachment of follicular keratinocytes, thereby releas-
ing inXammatory mediators, however, their precise role in
the development of acne has not been fully elucidated.
Proteases play an important role in skin homeostasis and
various disease conditions [7]. A number of biological activi-
ties of proteases are mediated, at least in part, via the activa-
tion of its receptor, protease-activated receptors (PARs) [7].
In the human skin, PAR-2 is abundantly expressed by kerati-
nocytes and seems to regulate permeability barrier homeosta-
sis, inXammation, pruritus, pigmentation, and wound healing
in response to various endogenous and exogenous serine pro-
teases [7]. Functional PAR-2 is also expressed by keratino-
cytes of hair follicles and sebaceous glands, Wbroblasts,
endothelium, aVerent neuron, as well as inXammatory cells
[29]. During cutaneous inXammation, PAR-2 is activated by
endogenous activators such as leukocyte elastase and mast
cell tryptase, thereby amplifying inXammation via upregula-
tion of inXammatory mediators [30]. PAR-2 is also known to
be activated by various pathogenic organisms with protease
activity such as house dust mites, cockroaches, certain
bacteria, or parasites [12, 32].
As P. acnes has been reported to produce various prote-
ases, exogenous proteases from P. acnes also can react with
PAR-2 on keratinocytes to induce and amplify inXamma-
tion in acne.
In this study, we investigated whether the culture super-
natant of P. acnes can activate PAR-2 on keratinocytes and
then induce the gene expression for pro-inXammatory cyto-
kines, antimicrobial peptides (AMPs), and matrix metallo-
proteinases (MMPs). In addition, we tested whether
protease activity of P. acnes supernatant and PAR-2 are
involved in the induction of these inXammatory mediators.
Materials and methods
Samples from patients
A total of six patients were enrolled in this study, with four
patients diagnosed with acne vulgaris and two patients with
nevus comedonicus. Skin of comedonal lesions were
obtained from the face of patients with acne vulgaris and
nevus comedonicus by 3-mm punch biopsy. The tissues
from acne patients were divided into two groups; one group
was Wxed in 10% buVered formalin for paraYn embedding,
and the other was embedded in optimal cutting temperature
compound and immediately frozen in liquid nitrogen, and
stored at ¡80°C for in situ zymography. All biopsies were
taken after obtaining informed consents from the patients,
and this study was approved by the institutional review
board of Severance Hospital, Yonsei University College of
Medicine, Seoul, Korea.
Measurement of protease activity by in situ zymography
Frozen sections (5 m thickness) were rinsed with washing
solution (1% Tween 20 in deionized water) and incubated
at 37°C for 1 h with 250 l of BODIPY-Fl-casein substrate
(1 g/l; EnZCheck® Protease Assay Kits, Molecular
Probes, Eugene, OR, USA) in deionized water (2 l/ml).
After removal of excess of substrate solution, nuclei were
stained with propidium iodide (PI; Sigma, MO, USA) and
the sections were washed with 1% Tween 20 in deionized
water. After incubation, the sections were rinsed with
washing solution and visualized immediately under confo-
cal microscope C1 Plus (Nikon, Japan).
ImmunoXuorescence study
ParaYn-embedded tissue sections were deparaYnized in
xylene and rehydrated in an ethanol series. Sections were
then incubated for 30 min in blocking buVer [1% BSA,
0.1% cold-water Wsh gelatin in phosphate-buVered saline
(PBS)]. For PAR-2 staining, sections were incubated with a
1:250 dilution of a rabbit polyclonal antibody against PAR-
2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA)
diluted in blocking buVer for 2 h at room temperature. After
washing with PBS, the sections were incubated with secondary
antibodies consisting of 1:100 dilution of FITC-labeled goat
anti-rabbit antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA) for 1 h at room temperature and diluted in
blocking buVer. Tissue sections then were washed with
PBS, and visualized under a confocal microscope C1 Plus
(Nikon, Japan).
Preparation of culture supernatant of P. acnes
Propionibacterium acnes (ATCC 6919, Manassas, VA,
USA) was grown in brain heart infusion broth (Difco,
Sparks, MD, USA) at 37°C for 24 h under anaerobic condi-
tion. The log phase culture was centrifuged at 5,000£g for
15 min. The supernatants were harvested, Wltered through a
0.2 m-pore size Wlter and then stored at ¡20°C until used.Arch Dermatol Res (2010) 302:745–756 747
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Protease activity measurement
To detect the secreted protease activity of P. acnes, the pro-
tease activity of the P. acnes culture supernatant was
assayed using an EnzChek Protease Assay Kit (Molecular
Probes Inc., Eugene, OR, USA). The pH-insensitive green
Xuorescent BODIPY-FL-conjugated casein was used as a
substrate. Trypsin type IX-S (Sigma Co., St Louis, MO,
USA), was used as a positive control. BODIPY-FL-conju-
gated casein solution (10 g/ml) was prepared with 10 mM
Tris–HCl buVer solution (pH 7.8) containing 0.1 mM
sodium azide. The exponential phase culture supernatant of
P. acnes strain ATCC 6919 was incubated with the sub-
strate in a 96-well plate (OptiPlate 96F; Perkin Elmer, Bos-
ton, MA, USA) according to the manufacturer’s protocol
for 1 h at 37°C and the Xuorescence was measured by the
HTS Multilabel Reader (Perkin Elmer, Boston, MA, USA)
with an excitation wavelength of 485 nm and an emission
wavelength of 530 nm.
Reagents
PAR-2 agonist peptide (AP) (SLIGKV-NH2) was pur-
chased from Peptron (Daejeon, Korea) and dissolved in
PBS at a concentration ranged from 0.3125 to 2.5 M. Ser-
ine protease inhibitor, PMSF (phenylmethyl sulfonyl Xuo-
ride) was purchased from Sigma Chemicals (St Louis, MO,
USA) and dissolved in ethanol, to a Wnal concentration of
1.5 mM. A novel and selective PAR2 antagonist, ENMD-
1068, was dissolved in PBS at a concentration ranged from
0.2 to 1.5 mM. The selectivity for PAR-2 in vivo in mice
and in vitro in both murine and human cell lines of this
PAR-2 antagonist was conWrmed previously [16].
Culture and stimulation of keratinocytes
The human keratinocyte cell line HaCaT grown to 80%
conXuency were maintained in EPILIFE Medium (Gibco,
Invitrogen Ltd., Paisley, UK) with human keratinocyte
growth supplement (Gibco, Invitrogen Ltd., Paisley, UK)
for 24 h before stimulation. HaCaT cells were treated with
the culture supernatant of P. acnes (2.5%) or AP (2.5M)
at the optimal concentration to induce the maximal calcium
inXux for 3, 6, 12, 18 h at 37°C/5% CO2 in culture medium.
In the inhibition study, cells were pretreated with PMSF
(1.5 mM) or ENMD-1068 (1.5 mM) for 30 min and 6 h,
respectively, and then treated with P. acnes culture super-
natant (2.5%) or AP (2.5 M) under the same condition.
Measurement of Ca2+ mobilization
We assessed PAR-2-mediated intracellular calcium mobili-
zation in keratinocytes using a Xuorometric imaging plate
reader (FLIPR) calcium assay kit (Molecular Devices, Sun-
nyvale, CA, USA). Keratinocytes were plated in 96-well
plates 24 h prior to the assay and grown to reach conXu-
ence at 37°C, 5% CO2. A calcium indicator dye (100 l
per well; FLIPR Calcium 4 assay kit; Molecular Devices,
Sunnyvale, CA, USA) was added, and then plates were
incubated for 1 h at 37°C. Test compound solutions were
prepared in vehicle, consisting of 20 mM HEPES in
Hank’s balanced salt solution (HBSS) with 0.1% BSA at
pH 7.4. Test solutions were added at 25 l to each well in
duplicate for each experiment. Test compounds were
added 30 min prior to the agonist stimulation. Then cells
were stimulated with various concentrations of AP or P. acnes
supernatant and the Xuorescence change measured at 25°C
(excitation 485 nm and emission 525 nm). ENMD-1068 was
added 30 min prior to the stimulation of cells. Inhibitory
eVects of ENMD-1068 on calcium responses were
expressed as percentage of the reference calcium response
induced by either AP (2.5 M) or P. acnes supernatant
(2.5%) alone.
Real-time reverse transcription-polymerase chain reaction 
(RT-PCR)
After treatment, the cells were harvested using 0.25% tryp-
sin/ethylene diamine tetra acetic acid (EDTA) and resus-
pended in PBS. Total RNA was extracted from the cells
using Trizol reagent (Invitrogen). The complementary
DNA was synthesized with 500 ng of total RNA using a
TaKaRa RNA PCR kit (AMV) Ver. 3.0 (Takara, Shuzo
Shiga, Japan). The primer sets were designed using NCBI
Primer-Blast. Real-time PCR was performed using the
SYBR Green PCR master mix and the ABI 7300 Real-
Time PCR System (Applied Biosystems, Foster City, CA,
USA) using the following parameters: 50°C for 2 min,
95°C for 10 min; 40 cycles of denaturation at 95°C for 15 s;
and primer extension at 60°C for 1 min. The expression of
-actin was used as reference. The PCR conditions for
human -actin were denaturation at 94°C for 1 min, anneal-
ing at 55°C for 1 min, and elongation at 72°C for 1 min for
30 cycles. All reactions were done in triplicate. Melting-
curve analysis of the PCR products was performed at the
end of each assay to conWrm the speciWcity of the ampliW-
cation and absence of primer dimers. The relative amount
of all mRNAs was calculated using the comparative thresh-
old (CT) method. Primers in the present study are shown in
Table 1.
Statistical analysis
All experiments were carried out in triplicate, and results
are expressed as mean § standard deviation. Comparisons
between tests were done by the Student’s t test.748 Arch Dermatol Res (2010) 302:745–756
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Results
Protease activity was increased in the lesional epithelium 
of acne vulgaris patients
Propionibacterium acnes has been shown to produce sev-
eral extracellular virulence factors including proteases
which may contribute to the pathogenesis of acne vulgaris.
To determine the presence of protease activity in vivo, we
performed in situ zymography analysis on the lesions of
acne patients. As shown by in situ zymography, protease
activity was increased in the lesional epithelium of acne
vulgaris patients (Fig. 1b) in comparison with that seen in
perilesional epidermis (Fig. 1a). Although the accurate
quantitative analysis of speciWc proteases were not possible
by zymography using BODIPY FL casein as a substrate,
the increased protease activity in acne lesions compared
with perilesional skin is thought to be due, in part, to the
P. acnes-derived proteases.
PAR-2 expression was upregulated in the comedone 
of acne vulgaris
Next, we assessed the expression pattern of PAR-2 in com-
edones obtained from patients with acne vulgaris. Comedo-
nal lesion of nevus comedonicus was used as a negative
control. As shown in Fig. 2, PAR-2 was highly expressed
in the suprabasal layers of follicular epithelium lining the
comedone obtained from acne patients. In contrast, the Xuo-
rescence intensity of PAR-2 was barely detected in the
comedone obtained from patients with nevus comedonicus.
Assay of protease activity
To estimate the secreted protease activity of P. acnes, the
exponential phase culture supernatant of P. acnes strain
ATCC 6919 was obtained and tested with a commercially
available protease assay, EnzChek (Molecular Probes) on a
casein substrate. Trypsin type IX-S (Sigma Co., St Louis,
Table 1 Primers for RT-PCR 
used in the present study
Mediator Gene Sense and antisense sequences
Pro-inXammatory cytokines IL-1 5-GACGCACTTGTAGCCACGTA-3
5-ACCGCCAATGAAATGACTCC-3
IL-6 5-GAAAGCAGCAAAGAGGCACT-3
5-TTTCACCAGGCAAGTCTCCT-3
IL-8 5-TCTGGCAACCCTAGTCTGCT-3
5-GCTTCCACATGTCCTCACAA-3
TNF- 5-ATGTTCGTCCTCCTCACAGG-3
5-CTATCTGGGAGGGGTCTTCC-3
Antimicrobial peptides hBD-2 5-CAGCCCATTGAAACCAACTT-3
5-CTCTGGTGCCTCTCAGAACC-3
LL-37 5-GACATGGGGACCATGAAGAC-3
5-AGGAGGCGGTAGAGGTTAGC-3
Matrix metalloproteinases MMP-1 5-CTGGCCACAACTGCCAAATG-3
5-CTGTCCCTGAACAGCCCAGTACTTA-3
MMP-2 5-TTGACGGTAAGGACGGACTC-3
5-ACTTGCAGTACTCCCCATCG-3
MMP-3 5-TGATCCTGCTTTGTCCTTTG-3
5-TTCAAGCTTCCTGAGGGATT-3
MMP-9 5-TTGACAGCGACAAGAAGTGG-3
5-GCCATTCACGTCGTCCTTAT-3
MMP-13 5-AACATCCAAAAACGCCAGAC-3
5-GGAAGTTCTGGCCAAAATGA-3
TIMP-1 5-AAGGCTCTGAAAAGGGCTTC-3
5-GAAAGATGGGAGTGGGAACA-3
TIMP-2 5-CCAAGCAGGAGTTTCTCGAC-3
5-GACCCATGGGATGAGTGTTT-3
Housekeeping gene -actin 5-TGAAGGTCGGAGTCAACGGATTTGT-3
5-CATGTGGGCCATGAGGTCCACCAC-3
IL interleukin, TNF tumor necro-
sis factor, hBD human beta 
defensin, MMP matrix 
metalloproteinase, TIMP tissue 
inhibitor of metalloproteinaseArch Dermatol Res (2010) 302:745–756 749
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MO, USA), was used as a positive control. The P. acnes
culture supernatant was observed to have 202.5 units/mL
protease activity (data not shown).
Proteases released by P. acnes activate PAR-2 in cultured 
keratinocytes
PAR-2 activation is known to stimulate mobilization of
intracellular calcium concentrations ([Ca2+]i) in keratino-
cytes [14]. To investigate that proteases from P. acnes are
potent activators of PAR-2, we assessed the eVects of
P. acnes supernatant on [Ca2+]i of keratinocytes. [Ca2+]i
was measured by calcium mobilization assay at diVerent
concentrations of P. acnes supernatant ranging from 0 to
2.5%. AP induced a signiWcant increase in relative Xuores-
cence intensity with the peak relative Xuorescence units
(RFU) around 40 s (Fig. 3a). The amplitude of the spike
was dependent on the concentration of AP. Similarly,
P. acnes supernatant induced an increase of [Ca2+]i, in a
dose-dependent manner comparable with AP, as a positive
control (Fig. 3b). ENMD-1068 dose-dependently inhibited
the calcium inXux in response to P. acnes supernatant
(Fig. 3c). To clarify whether the eVect of P. acnes superna-
tant on [Ca2+]i increases was mediated by PAR-2, desensiti-
zation protocol was performed as described in previous
studies [17, 18]. Receptor desensitization by repeated treat-
ment with 2.5% P. acnes supernatant abolished the intracel-
lular calcium signaling in response to AP, suggesting that
P. acnes supernatant targets the same receptor with AP
(Fig. 3d). These results indicate that P. acnes supernatant-
induced intracellular calcium signaling in keratinocytes is
mediated by PAR-2 activation.
Propionibacterium acnes culture supernatant stimulates 
mRNA expression of inXammatory cytokines via protease/
PAR signaling in keratinocytes
Next, we investigated whether the activation of PAR-2 by
P. acnes culture supernatant is involved in the regulation of
inXammatory cytokine gene expression. Keratinocytes
were incubated for 18 h with P. acnes culture supernatant
(2.5%) at the concentration of maximum response in intra-
cellular calcium levels. Then the transcript level of IL-1,
IL-6, IL-8, and TNF- in the culture medium was measured
by RT-PCR. Propionibacterium acnes supernatant signiW-
cantly increased the mRNA expression of IL-1, IL-6, IL-8,
and TNF- in keratinocytes to a comparable level to that of
AP-treated keratinocytes, as positive controls (Fig. 4).
To determine whether this upregulation was due to the
protease activity, we assessed the eVect of serine protease
inhibitor. Pretreatment with a serine protease inhibitor
(PMSF) signiWcantly abolished the P. acnes culture super-
natant-induced upregulation of IL-1, IL-8, and TNF-
mRNA expression (Fig. 4). Next we showed that pretreat-
ment with a selective PAR-2 antagonist, ENMD-1068 sig-
niWcantly inhibited the induction of IL-1, IL-8, and TNF-
mRNA expression in response to P. acnes culture superna-
tant (Fig. 4). These Wndings suggest that serine protease
activity of P. acnes supernatant induces IL-1, IL-8, and
TNF- gene expression in keratinocytes partially via PAR-2
activation.
Propionibacterium acnes culture supernatant stimulates 
mRNA expression of hBD-2 and LL-37 via protease/PAR 
signaling in keratinocytes
Keratinocytes treated with P. acnes culture supernatant
for 12 h showed increased mRNA level of hBD-2 and
LL-37 by about 7- and 4.5-fold, respectively, compared to
that of untreated cells (Fig. 5a). Since the peak expression
of hBD-2 and LL-37 mRNA occurred after 12 h of treat-
Fig. 1 In situ zymography analysis. Total protease activities of the le-
sions and perilesional normal-appearing skin obtained from acne pa-
tients were detected by the degradation of the BODIPY FL casein
substrate. Protease activity was observed as the intensity of green Xuo-
rescence. Lesions of acne showed higher protease activity compared to
the perilesional normal-appearing skin. SC stratum corneum, SG stra-
tum granulosum, SB stratum basale750 Arch Dermatol Res (2010) 302:745–756
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ment in our preliminary study (data not shown), this time
point was chosen for the next assay to investigate the abil-
ity of serine protease inhibitor and PAR-2 antagonist to
inhibit AMP gene expression. Pretreatment with a PMSF
signiWcantly suppressed the P. acnes supernatant-induced
upregulation of hBD-2 and LL-37 mRNA level, suggest-
ing that serine protease activity is involved in this induc-
tion (Fig. 5a). To assess the role of PAR-2 in P. acnes
culture supernatant-induced AMP gene expression, cells
were pretreated with ENMD-1068 and then stimulated
with P. acnes culture supernatant for 12 h. The P. acnes
supernatant-induced upregulation of hBD-2 gene expres-
sion was signiWcantly suppressed by ENMD-1068, whereas,
expression of LL-37 gene was suppressed slightly by
ENMD-1068, however, the suppression was not statisti-
cally signiWcant (Fig. 5a).
Conversely, treatment of keratinocytes with AP signiW-
cantly increased hBD-2 and LL-37 expression. As shown
in Fig. 5b, hBD-2 mRNA level was increased by about
5.5-fold at 3 h and about tenfold at 6 h after the treatment
with AP compared to that of untreated cells. LL-37
mRNA level was maximally increased by about eightfold
after 3 h treatment with AP. These results suggest that
protease activity of P. acnes supernatant stimulates hBD-2
and LL-37 release from keratinocytes partially via activation
of PAR-2.
Propionibacterium acnes culture supernatant increases 
mRNA expression of MMP-1, -2, -3, -9, and -13, 
but not tissue inhibitor of metalloproteinases (TIMP)-1 
and -2
The eVect of P. acnes supernatant on the gene expression of
MMPs and TIMPs in keratinocytes was investigated by
RT-PCR analysis. As shown in Fig. 6a, HaCaT cells treated
with P. acnes supernatant for 18 h demonstrated a signiW-
cant increase in the mRNA level of MMP-1, -2, -3, -9, and
-13 by about 9-, 5-, 14-, 17-, and 5.5-fold, respectively,
compared to that of untreated cells. However, the gene
expression of TIMP-1 and -2 was not aVected by P. acnes
supernatant after 12 h and 18 h treatment (Fig. 6b).
Protease activity of P. acnes culture supernatant stimulates 
mRNA expression of MMP-1, -2, -3, -9, and -13 via PAR-2 
activation in keratinocytes
Then we assessed the eVect of PMSF or ENMD-1068 on
this upregulation (Fig. 6e). The peak expression of MMPs
mRNA occurred after 18 h of treatment with P. acnes
supernatant (Fig. 6a), this time point was chosen for the
next assay to investigate the ability of serine protease inhib-
itor and PAR-2 antagonist to inhibit MMPs gene expres-
sion. Pretreatment with a PMSF signiWcantly inhibited the
Fig. 2 PAR-2 expression in the 
comedonal lesions of patients 
with acne vulgaris and nevus 
comedonicus. PAR-2 immuno-
staining was performed using 
rabbit polyclonal anti-PAR-2 
(H99, Santa Cruz Biotechnol-
ogy, CA, USA) antibody and 
FITC-labeled goat anti-rabbit 
antibody (Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA, 
USA). Immunoreactivity of 
PAR-2 was highly expressed in 
comedone of patients with acne 
vulgaris (a) in comparison to 
that of patients with nevus 
comedonicus (b). (c) and 
(d) Enlarged views in the white 
box in a and b, respectivelyArch Dermatol Res (2010) 302:745–756 751
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P. acnes supernatant-induced upregulation of MMP-1, -2,
-3, -9, and -13 mRNA level, suggesting that protease activ-
ity of P. acnes supernatant is involved in the stimulation of
MMPs gene expression. ENMD-1068 also signiWcantly
inhibited the upregulation of MMP-1, -2, -3, -9, and -13
mRNA level by P. acnes supernatant. To further support
the role of PAR-2 in regulating P. acnes supernatant-
induced gene expression of MMPs, we directly stimulated
keratinocytes with AP (Fig. 6c). AP signiWcantly increased
the mRNA level of MMP-1, -3, -9, and -13 by about 5-,
20-, 18-, and 5-fold, respectively, compared to that of
untreated cells after 6 h co-culture. The peaks of these
mRNA expressions were at 6 h. For MMP-2, AP signiW-
cantly increased its mRNA level by about 4.5-fold at 6 h,
and its level continued to increase by about 17.5-fold at
18 h. These results suggest that P. acnes supernatant-
induced gene expression of MMP-1, -2, -3, -9, and -13 in
keratinocytes is mediated the activation of PAR-2.
Discussion
PAR-2 is known to be expressed in the adnexal structures
of the skin. As a sensor for exogenous or endogenous dan-
ger molecules, PAR-2 activation is tightly regulated by
endogenous serine proteases as well as by secreted prote-
ases from various microbes [29, 30]. In previous studies,
P. acnes was found to produce various proteases and con-
tribute to tissue injury [8, 10, 28]. In addition to this direct
proteolytic eVect, proteases derived from P. acnes could be
potential activators of PAR-2 and activate innate immune
response and inXammation. However, the possible role of
PAR-2 in the pathogenesis of acne has not been investi-
gated. Consistent with previous studies, we demonstrated
that the culture supernatant of P. acnes strain ATCC 6919
in the exponential phase of growth had proteolytic activity
with a casein substrate (data not shown). We also showed
that the protease activity was increased in follicular
Fig. 3 PAR-2 activation induced by the culture supernatant of P. ac-
nes ATCC6919. HaCaT cells were stimulated with SLIGKV (a)o r
P. acnes supernatant (b), and intracellular Ca2+ mobilization was mea-
sured using a Xuorescence method as described in the materals and
methods section. Fluorescence was measured over 120 s. ENMD-1068
was incubated with cells 6 h prior to addition of agonist stimulation (c).
Desensitization protocol showed that these calcium responses are in-
duced via PAR-2 signaling (d). RFU relative Xuorescence units752 Arch Dermatol Res (2010) 302:745–756
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epithelium of acne lesion compared to that of non-lesional
normal epidermis by in situ zymography, suggesting that
the proteases secreted by P. acnes might be attributed to the
higher protease activity in acne lesions. Then we demon-
strated that the culture supernatant of P. acnes induced
intracellular calcium inXux and desensitized PAR-2 activa-
tion, suggesting that the proteases derived from P. acnes
can proteolytically activate PAR-2 on keratinocytes. To
further conWrm the involvement of P. acnes proteases in the
PAR-2 expression in comedonal lesions of acne, we com-
pared the expression of PAR-2 immunoreactivity in the
comedo of acne vulgaris and nevus comedonicus. As a neg-
ative control, we used the lesion of nevus comedonicus,
because it is characterized by the abnormal keratinization
and comedo formation similar to acne vulgaris without col-
onization of P. acnes [19]. PAR-2 immunoreactivity was
upregulated in the follicular wall of comedones of acne vul-
garis in compared with that of nevus comedonicus. Taken
together we hypothesized that protease/PAR-2 signaling
might have an important role in acne pathogenesis. Based
on this hypothesis, we investigated whether P. acnes-
derived protease activity is able to stimulate keratinocytes
to induce inXammatory mediators via PAR-2 activation.
The culture supernatant of P. acnes increased the gene
expression of IL-1, IL-6, IL-8, and TNF- in keratino-
cytes. The induction of IL-1, IL-8, and TNF- mRNA
expression was signiWcantly inhibited by incubating
P. acnes culture supernatants with serine protease inhibitor
or selective PAR-2 antagonist, suggesting that P. acnes
proteases contribute to the upregulation of IL-1, IL-8, and
TNF- via PAR-2 activation, thereby attributes to the com-
edo formation [9], neutrophil inWltration [1], and sustained
inXammation in the acne pathogenesis. Viable P. acnes in
the exponential and stationary phase of growth was found
to stimulate the production of TNF- and granulocyte mac-
rophage-colony stimulating factor (GM-CSF) by human
keratinocytes [6]. Viable P. acnes in the stationary phase of
growth also reported to contribute to IL-1 production in
keratinocytes [6]. In addition, it is well established that
P. acnes induces keratinocyte IL-8 production through a
TLR2-dependent pathway [24]. In the present study we
demonstrated that P. acnes proteases induce the gene
Fig. 4 EVects of serine protease inhibitor or PAR-2 speciWc antagonist
on P. acnes supernatant-induced mRNA expression of pro-inXammatory
cytokines in HaCaT cells. The mRNA expression levels of IL-1,
IL-6, IL-8, and TNF- in HaCaT cells treated with the culture superna-
tant of P. acnes for 18 h with or without pretreatment with serine
protease inhibitor or selective PAR-2 antagonist were determined using
RT-PCR. The mRNA levels were normalized to human -actin and are
presented as fold increases over the control (untreated cells) values.
Data are mean § standard deviation. Asterisks indicate statistically
signiWcant diVerences (*P <0 . 0 5 ,  * * P < 0.01) versus the control. Dou-
ble crosses indicate statistically signiWcant diVerences (#P · 0.05,
##P · 0.01) between the P. acnes sup-treated and inhibitor-pretreated
group
Fig. 5 EVects of serine protease inhibitor or selective PAR-2 antago-
nist on P. acnes culture supernatant-induced mRNA expression of anti-
microbial peptides in HaCaT cells. The mRNA expression levels of
hBD-2 and LL-37 in HaCaT cells treated with the culture supernatant
of P. acnes ATCC6919 for 12 h (a) or AP for 3, 6, and 12 h (b)w e r e
determined using RT-PCR. The mRNA levels were shown as a fold in-
crease versus 0 h untreated samples (b). Cells were pretreated with ser-
ine protease inhibitor or selective PAR-2 antagonist and then
stimulated with P. acnes supernatant for 12 h (a). The mRNA levels
were normalized to human -actin and are presented as fold increases
over the control (untreated cells) values. Data are mean § standard
deviation.  Asterisks indicate statistically signiWcant diVerences
(*P < 0.05, **P < 0.01) vs the control. Double crosses indicate statis-
tically signiWcant diVerences (#P · 0.05,  ##P · 0.01) between the
P. acnes sup-treated and inhibitor-pretreated groupArch Dermatol Res (2010) 302:745–756 753
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expression of proinXammatory cytokines in keratinocytes
via activation of PAR-2. These results are agreement with
previous studies which reported that several pathogen-
derived serine proteases are able to activate PAR-2, thereby
inducing inXammation [14,  31]. Protease derived from
Aggregatibacter actinomycetemcomitans extracts was dem-
onstrated to upregulate IL-8 and intercellular adhesion mol-
ecule-1 expression in human gingival cells via PAR-2
activation [31]. Recent study also showed that serine prote-
ases in mite culture extracts activated PAR-2 on keratino-
cytes leading to upregulation of IL-8 and GM-CSF [14].
Next, we demonstrated that the P. acnes supernatant
increased the gene expression of hBD-2 and LL-37 in
keratinocytes, which was blocked by serine protease
Fig. 6 EVects of serine protease inhibitor or selective PAR-2 antago-
nist on P. acnes culture supernatant-induced mRNA expression of ma-
trix metalloproteinases in HaCaT cells. The mRNA expression levels
of MMP-1, -2, -3, -9, -13, TIMP-1, and -2 in HaCaT cells treated with
the culture supernatant of P. acnes ATCC6919 for 12 and 18 h (a, b)o r
AP for 3, 6, 12, and 18 h (c, d) were determined using RT-PCR. The
mRNA levels were shown as a fold increase versus 0 h untreated sam-
ples (a–d). Cells were pretreated with serine protease inhibitor or
selective PAR-2 antagonist and then stimulated with P. acnes superna-
tant for 18 h and assessed the mRNA expression levels of MMP-1, -2,
-3, -9, and -13 (e). The mRNA levels were normalized to human -ac-
tin and are presented as fold increases over the control (untreated cells)
values. Data are mean § standard deviation. Asterisks indicate statis-
tically signiWcant diVerences (*P <0 . 0 5 ,  * * P < 0.01) versus the con-
trol.  Double crosses indicate statistically signiWcant diVerences
(#P · 0.05, ##P · 0.01) between the P. acnes sup-treated and inhibi-
tor-pretreated group754 Arch Dermatol Res (2010) 302:745–756
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inhibitor as well as PAR-2 speciWc inhibitor, suggesting
that P. acnes-derived protease contributes to these AMPs
induction via PAR-2.
Our Wndings are consistent with previous studies which
demonstrated that PAR-2 stimulation on gingival epithelial
cells by Porphyromonas gingivalis-secreted proteases led
to an upregulation of hBD-2 expression [5]. In addition,
immunoglobulin A in human milk with protease activity
has been demonstrated to activate PAR-2 on intestinal epi-
thelium, inducing hBD-2 expression via PAR-2 signaling
[2]. Previous study showed that hBD-2 expression is upreg-
ulated in acne lesions, suggesting the role of hBD-2 in acne
pathogenesis [27]. Nagy et al. found that P. acnes induced
hBD-2 in keratinocytes through TLR-2 and -4 and reported
that hBD-2 does not have any bacteriostatic or bactericidal
eVect against any of the four P. acnes strains they used,
suggesting that the primary contribution of hBD2 to acne
pathogenesis is the regulation of adaptive immunity [24]. In
contrast, Nakatsuji et al. demonstrated that high concentra-
tions of synthetic hBD-2 (5–20 M) had bactericidal eVect
on P. acnes (ATCC 6919), dose dependently [25]. These
observations suggest that hBD-2 has a dual role in the path-
ogenesis of acne: the protective role against P. acnes colo-
nization when its local concentration rises above the
bactericidal level and the role of innate immune responses
and cutaneous inXammation. Nakatsuji et al. demonstrated
that sebum free fatty acids (FFAs) enhanced hBD-2 mRNA
levels up to 45,260-fold in sebocytes and that the FFA-
induced sebocyte culture supernatant showed antimicrobial
activity against P. acnes [ 25]. Our results showed that
P. acnes culture supernatant or AP treatment of keratinocytes
signiWcantly induced the gene expression of hBD-2 by sev-
enfold or tenfold, respectively, but to a lesser extent than in
a previous report [25]. These observations may require fur-
ther study to investigate the clinical signiWcance of PAR-2-
mediated hBD-2 induction in response to P. acnes.
The regulation and role of cathelicidins, which are
another group of AMPs, in acne are largely unknown. Cath-
elicidins are reported to be controlled at transcriptional and
post-transcriptional level by infection, inXammation, and
1,25-dihydroxyvitamin D3 [20]. Our results demonstrated
that  P. acnes-derived protease and PAR-2 signaling
induced the upregulation of cathelicidin expression in
keratinocytes. The importance of serine protease-mediated
proteolysis in the regulation of the antimicrobial eVects of
cathelicidin has been well known. Recent study observed
increased protease activity and cathelicidin expression in
the lesions of rosacea patients and suggested that increased
protease activity leads to abnormal cathelicidin processing,
thereby promotes inXammation in rosacea [34]. However,
this protease-induced activation of cathelicidin was post-
transcriptional regulation. Taken together, it remains to be
determined whether the increased gene expression of LL-37
in response to P. acnes supernatant in our study is a
nonspeciWc reaction to inXammatory cytokines or a more
speciWc response to protease/PAR-2 signaling.
Recently, an active role of MMPs in acne has become an
interesting topic of research in acne pathogenesis [11, 26].
Papakonstantinou et al. reported that facial sebum from
acne patients contained MMP-1, MMP-13, TIMP-1, and
TIMP-2, which are thought to originate in keratinocytes
and sebocytes [26]. A recent in vitro study by Jalian et al.
demonstrated that P. acnes induced MMP-9, MMP-1, and
TIMP-1 transcript in human monocytes [11]. We demon-
strated here that keratinocytes are important source of
MMPs in acne and that protease activity of P. acnes could
induce the expression of several MMPs, including MMP-1,
-2, -3, -9, and -13 via PAR-2 activation. We also observed
that MMP-1, -2, -3, and -9 were signiWcantly upregulated in
acne lesions by immunohistochemistry (data not shown) as
previous study which showed that MMP-1, -3, and -9 were
markedly elevated in inXammatory acne lesions [15].
Although the mechanism underlying the elevation of
MMPs in acne lesions has not been fully elucidated, one
report suggested that the enhanced expression of activator
protein-1 (AP-1) regulated MMPs in inXammatory acne
lesions by demonstrating that AP-1 was activated in acne
lesions [15]. Retinoids, which are known to modulate AP-1
expression, have been demonstrated to reduce MMP-9 and
-13 in sebum of acne patients [26], whereas, upregulate
TIMP-1 in vitro [11], thereby inducing clinical improve-
ment of acne. It was reported that PAR-2 induced c-Jun/
AP-1 activation via Jun activation domain-binding protein
1 (Jab1)-mediated signaling pathway [21]. These data led
us to suggest that PAR-2-induced AP-1 activation may
stimulate MMPs in keratinocytes when exposed to P. acnes
with protease activity. The upregulated MMPs might con-
tribute to the acne pathogenesis by inducing inXammation
and tissue destruction.
It has been known that there are two distinct types of
P. acnes (types I and II) based on serological agglutination
tests and cell-wall sugar analysis [13]. Recent studies have
proWled these two phenotypes of P. acnes using nucleotide
sequencing of the recA housekeeping gene, demonstrating
that types I and II represent phylogenetically distinct lin-
eages and the type I strains could be split into two further
clusters, types IA and IB [22]. Because of the antigenic and
biochemical diVerences between these phylogenetic types
of P. acnes, including the expression of putative Christie–
Atkins–Munch–Peterson (CAMP) factor [33], a number of
recent studies have attempted to correlate the diVerent phy-
logenetic types of P. acnes with their diVerent role in acne
pathogenesis [23,  24]. The P. acnes strain ATCC 6919,
which we used in our study, belongs to the P. acnes type IA
strain [33]. A previous microbiological study has found that
P. acnes isolates from patients with acne were predominantlyArch Dermatol Res (2010) 302:745–756 755
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type IA [22] and type IA isolates have been demonstrated
to have a greater eVect on AMPs and proinXammatory
cytokines production by keratinocytes [24] and sebocytes
[23]. However, the lesions of acne patients are likely to har-
bor diVerent skin microbes and P. acnes strains other than
type IA. From these Wndings, our study has a limitation that
should be taken into account in interpreting the results. It
should be noted that our data obtained with only one isolate
type of P. acnes, do not necessarily translate into other
phylogenetic types of P. acnes and their role in acne patho-
genesis. Moreover, in future study it might be worthwhile
to investigate the possible involvement of PAR-2 in the
pathogenesis of acne using the diVerent other phylogenetic
types of P. acnes.
In conclusion, our results indicate that PAR-2 is an
important sensor for exogenous danger molecules, such as
exogenous proteases from P. acnes, and plays an important
role in acne pathogenesis by inducing inXammation, innate
immune responses, and acne scar formation. Together,
these Wnding also suggest that speciWc protease activity or
PAR-2 might be a future target for therapeutic intervention
for the treatment of acne vulgaris.
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